Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities
暂无分享,去创建一个
Christopher McCabe | Richard Edlin | David Meads | Chantelle Brown | Samer Kharroubi | R. Edlin | C. McCabe | D. Meads | S. Kharroubi | Chantelle Brown
[1] Philip Quirke,et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial , 2005, The Lancet.
[2] A. Brennan,et al. Should patients have a greater role in valuing health states? , 2005, Applied health economics and health policy.
[3] K. Perampaladas,et al. Comparing EQ-5D Valuation Studies , 2014, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] Casper J. P. Zhang,et al. INTERIM SCORING FOR THE EQ-5 D-5 L : MAPPING THE EQ-5 D-5 L TO EQ-5 D-3 L VALUE SETS Methodology , 2011 .
[5] Nicky J Welton,et al. Evidence Synthesis for Decision Making in Healthcare: Welton/Evidence Synthesis for Decision Making in Healthcare , 2012 .
[6] Urs E. Studer,et al. Немедленная и отсроченная андрогенная блокада у больных раком предстательной железы, которым не показано местное радикальное лечение: исследование 30891 European Organisation for Research and Treatment of Cancer (EORTC) , 2006 .
[7] K. Perampaladas,et al. Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist , 2013 .
[8] Mark Oppe,et al. From a different angle: a novel approach to health valuation. , 2010, Social science & medicine.
[9] Christopher McCabe,et al. Health state values for the HUI 2 descriptive system: results from a UK survey. , 2005, Health economics.
[10] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] Albert W Wu,et al. Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. , 2007, Health services research.
[12] P. Dolan. Modelling valuations for health states , 1997 .
[13] K Claxton,et al. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. , 2012, Health technology assessment.
[14] Christopher McCabe,et al. Title : Modelling HUI 2 health state preference data using a nonparametric Bayesian method , 2006 .
[15] Allan Wailoo,et al. Tails from the Peak District: adjusted censored mixture models of EQ-5D health state utility values , 2010 .
[16] J Brazier,et al. NICE DSU Technical Support Document 8: An Introduction to the Measurement and Valuation of Health for NICE Submissions [Internet] , 2011 .
[17] Julie Ratcliffe,et al. Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[18] J. Brazier,et al. The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.
[19] John Brazier,et al. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[20] Nicky J Welton,et al. Evidence Synthesis for Decision Making in Healthcare (Statistics in Practice) , 2012 .
[21] Michael Donnelly,et al. The measurement of health-related quality of life , 2001 .
[22] Jenny Hewison,et al. The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer , 2012, BMC Cancer.
[23] Nicky J Welton,et al. NICE DSU Technical Support Document 18 , 2011 .
[24] Donna Rowen,et al. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[25] M. Mcgrath. Cost Effectiveness in Health and Medicine. , 1998 .
[26] Peter C Austin,et al. A comparison of methods for analyzing health-related quality-of-life measures. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.